Zeiss and Envision Health partner on VR-based glaucoma testing
Go back to Zeiss and Envision Health partner on VR-based glaucoma testing| Carl Zeiss Meditec AG Unsponsored ADR (AMEX: CZMWY) | Delayed: 31.63 -0.02 (0.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.65 | 52 Week High | $41.68 | |||
| Open | $32.05 | 52 Week Low | $28.06 | |||
| Day High | $32.05 | P/E | N/A | |||
| Day Low | $31.54 | EPS | $0.00 | |||
| Volume | 5,043 | |||||
